RESUMO
Paternal stress exposure-induced high corticosterone (CORT) levels may contribute to depression in offspring. Clinical studies disclose the association of depressive symptoms in fathers with their adolescent offspring. However, there is limited information regarding the intervention for intergenerational inheritance of depression. In this study we evaluated the intervention of cinnamaldehyde, a major constituent of Chinese herb cinnamon bark, for intergenerational inheritance of depression in CORT- and CMS-induced mouse models of depression. Depressive-like behaviors were induced in male mice by injection of CORT (20 mg·kg-1·d-1, sc) for 6 weeks or by chronic mild stress (CMS) for 6 weeks. We showed that co-administration of cinnamaldehyde (10, 20, or 40 mg·kg-1·d-1, ig) for 6 weeks in F0 males prevented the depressive-like phenotypes of F1 male offspring. In addition, co-administration of cinnamaldehyde (20 mg·kg-1·d-1, ig) for 4 weeks significantly ameliorated depressive-like behaviors of chronic variable stress (CVS)-stimulated F1 offspring born to CMS mice. Notably, cinnamaldehyde had no reproductive toxicity, while positive drug fluoxetine showed remarkable reproductive toxicity. We revealed that CMS and CORT significantly reduced testis glucocorticoid receptor (GR) expression, and increased testis and sperm miR-190b expression in F0 depressive-like models. Moreover, pre-miR-190b expression was upregulated in testis of F0 males. The amount of GR on miR-190b promoter regions was decreased in testis of CORT-stimulated F0 males. Cinnamaldehyde administration reversed CORT-induced GR reduction in testis, miR-190b upregulation in testis and sperm, pre-miR-190b upregulation in testis, and the amount of GR on miR-190b promoter regions of F0 males. In miR-190b-transfected Neuro 2a (N2a) cells, we demonstrated that miR-190b might directly bind to the 3'-UTR of brain-derived neurotrophic factor (BDNF). In the hippocampus of F1 males of CORT- or CMS-induced depressive-like models, increased miR-190b expression was accompanied by reduced BDNF and GR, which were ameliorated by cinnamaldehyde. In conclusion, cinnamaldehyde is a potential intervening agent for intergenerational inheritance of depression, probably by regulating GR/miR-190b/BDNF pathway.
Assuntos
Acroleína , Fator Neurotrófico Derivado do Encéfalo , Depressão , MicroRNAs , Receptores de Glucocorticoides , Acroleína/análogos & derivados , Acroleína/farmacologia , Animais , Fator Neurotrófico Derivado do Encéfalo/metabolismo , Corticosterona/metabolismo , Depressão/tratamento farmacológico , Depressão/genética , Pai/psicologia , Hipocampo/metabolismo , Humanos , Masculino , Camundongos , MicroRNAs/metabolismo , Herança Paterna , Receptores de Glucocorticoides/metabolismo , Sêmen/metabolismoRESUMO
Pre-eclampsia is a pregnancy-related disease that may cause maternal, neonatal and fetal morbidity and mortality and exists in 3-5% of pregnancies worldwide. The discovery of dysregulated microRNAs and their roles in placental development has provided a new avenue for elucidating the mechanism involved in this pregnancy-specific disorder. Here, the roles of human miR-181a-5p, a microRNA that is increased in both the plasma and placenta of severe pre-eclamptic patients, in invasion and migration of trophoblasts were investigated. Ectopic-expression of miR-181a-5p impaired the invasion and migration of HTR-8/SVneo cells, whereas miR-181a-5p inhibition had the opposite effects. IGF2BP2, which harbors a highly conserved miR-181a-5p-binding site within its 3'-UTR, was identified to be directly inhibited by miR-181a-5p. Moreover, siRNAs targeting IGF2BP2 imitated the effects of overexpressed miR-181a-5p on HTR-8/SVneo cell invasion and migration, whereas restoring IGF2BP2 expression by overexpressing a plasmid encoding IGF2BP2 partially reversed the studied inhibitory functions of miR-181a-5p. Thus, we demonstrated here that miR-181a-5p suppresses the invasion and migration of cytotrophoblasts, and its inhibitory effects were at least partially mediated by the suppression of IGF2BP2 expression, thus shedding new light on the roles of miR-181a-5p in the pathogenesis of severe pre-eclampsia.
Assuntos
Movimento Celular , MicroRNAs/metabolismo , Proteínas de Ligação a RNA/metabolismo , Trofoblastos/metabolismo , Trofoblastos/patologia , Regiões 3' não Traduzidas/genética , Adulto , Sequência de Bases , Sítios de Ligação , Linhagem Celular , Movimento Celular/genética , Sequência Conservada , Feminino , Humanos , MicroRNAs/genética , Pré-Eclâmpsia/genética , Pré-Eclâmpsia/patologia , Gravidez , Ligação Proteica , RNA Interferente Pequeno/metabolismo , Proteínas de Ligação a RNA/genética , Regulação para Cima/genéticaRESUMO
OBJECTIVE: To investigate the association of maternal body composition and dietary intake with the risk of gestational diabetes mellitus (GDM). METHODS: A total 154 GDM subjects and 981 controls were enrolled in a prospective cohort study in 11 hospitals from May 20, 2012 to December 31, 2013. Bioelectrical impedance analysis and dietary surveys were used to determine body composition and to evaluate the intake of nutrients in subjects at 21-24 weeks' gestation (WG). Logistic regression analysis was applied to explore the relationships of maternal body composition and dietary intake with the risk of GDM morbidity. RESULTS: Age, pre-pregnant body weight (BW), and body mass index (BMI) were associated with increased risk of GDM. Fat mass (FM), fat mass percentage (FMP), extracellular water (ECW), BMI, BW, energy, protein, fat, and carbohydrates at 21-24 WG were associated with an increased risk of GDM. In contrast, fat free mass (FFM), muscular mass (MM), and intracellular water (ICW) were associated with a decreased risk of GDM. CONCLUSION: Maternal body composition and dietary intake during the second trimester of pregnancy were associated with the risk of GDM morbidity.
Assuntos
Composição Corporal , Diabetes Gestacional/epidemiologia , Dieta , Comportamento Alimentar , Segundo Trimestre da Gravidez , Adulto , Povo Asiático , Índice de Massa Corporal , Estudos de Coortes , Inquéritos sobre Dietas , Feminino , Humanos , Gravidez , Fatores de RiscoRESUMO
The human leukocyte antigen G (HLA-G) is expressed on the fetal-maternal interface and plays a role in protecting fetal-derived trophoblasts from the maternal immune response, allowing trophoblasts to invade the uterus. However, HLA-G also possesses immune suppressing-independent functions. We found that HLA-G expressing BeWo choriocarcinoma cells increased cell-cell fusion compared to control BeWo cells under forskolin treatment. Regardless of forskolin treatment, the expression of fusogenic gene mRNAs, including syncytin-1, the transcription factor glial cell missing 1 (Gcm1), and beta human chorionic gonadotropin (ß-hCG) were elevated. HLA-G up-regulates ß-hCG production in human choriocarcinoma cells because HLA-G knockdown in JEG-3 cells induces a dramatic decrease in ß-hCG compared with control cells. The defect in ß-hCG production in HLA-G knocked-down cells could not be completely overcome by stimulating hCG production through increasing intracellular cAMP levels. HLA-G expressing cells have increased phosphorylation levels for extracellular signal-regulated kinase1/2 (Erk1/2) in BeWo cells. The Erk1/2 pathway is inactivated after the inhibition of HLA-G expression in JEG-3 cells. Finally, Erk1/2 inhibition was able to suppress the increased hCG production induced by HLA-G expression. Together, these data suggest novel roles for HLA-G in regulating ß-hCG production via the modulation of the Erk1/2 pathway and by inducing trophoblast cell fusion.
Assuntos
Fusão Celular , Coriocarcinoma/imunologia , Gonadotropina Coriônica/biossíntese , Antígenos HLA-G/imunologia , Sistema de Sinalização das MAP Quinases , Trofoblastos/citologia , Sequência de Bases , Western Blotting , Linhagem Celular Tumoral , Coriocarcinoma/metabolismo , Coriocarcinoma/patologia , Primers do DNA , Imunofluorescência , Técnicas de Silenciamento de Genes , Antígenos HLA-G/genética , Humanos , Reação em Cadeia da Polimerase em Tempo Real , Regulação para CimaRESUMO
OBJECTIVE: To observe change of expression level of Connexin 43 (Cx 43) in myocardial mitochondria of ischemia reperfusion injury after pretreatment of acupuncture and moxibustion at "Neiguan" (PC 6) in rabbits, Thirty-two New Zealand and compare the different effect between electroacupuncture and moxibustion. METHODS: big-eared white rabbits were randomly divided into a model group, an electroacupuncture group, a moxibustion group and a sham-operation group, 8 cases in each one. The model of myocardial ischemia reperfusion injury was established in the first three groups. Before and after animal model was successfully made, the electroacupuncture and moxibustion were applied at "Neiguan" (PC 6) for 20 min respectively in the electroacupuncture group and moxibustion group. After the experiment, distribution of Cx 43 was observed under optical microscope while mean value of integral optical density (IOD) of Cx 43 in myocardial cell was tested. RESULTS: The distribution of Cx 43 in the model group was obviously scattered and sparse, but more expression of Cx 43 could be seen in the other three groups that were shaped as strip, chain or irregular and was perpendicular to cell long axis or formed side-side connection that was parallel to long axis. Shape and distribution of Cx 43 expression in the moxibustion group were not obviously different from that in the electroacupuncture group. The mean value of IOD of Cx 43 expression in myocardial cell in the electroacupuncture group (735. 10 +/- 152. 01), moxibustion group (836. 15 +/- 247. 10) and sham-operation group (950.56+/-223.37) was higher than that in the model group (312. 68+/-1105. 20), and difference of the mean value in the electroacupuncture group was not statistically significant from that in the moxibustion group. CONCLUSION: The pretreatment of acupuncture and moxibustion at "Neiguan" (PC 6) in rabbit could increase expression of Cx 43 in myocardial cell and participate in electrical coupling and metabolic coupling to protect myocardial cell from ischemia reperfusion. However, differences of mean value of Cx 43 expression in myocardial cell were not statistically significant during electroacupuncture and moxibustion at "Neiguan" (PC 6).
Assuntos
Pontos de Acupuntura , Conexina 43/genética , Eletroacupuntura , Moxibustão , Isquemia Miocárdica/genética , Isquemia Miocárdica/terapia , Miocárdio/metabolismo , Animais , Conexina 43/metabolismo , Feminino , Humanos , Masculino , Isquemia Miocárdica/metabolismo , Isquemia Miocárdica/cirurgia , Miocárdio/citologia , Coelhos , ReperfusãoRESUMO
OBJECTIVE: To investigate the value of detection of fetal cell-free fetal DNA (cff-DNA) in maternal plasma in the prenatal diagnosis of chromosomal abnormalities. METHODS: The plasma from 3200 gravidas (singleton with 20.3 ± 3.8 gestational weeks) was collected from April 1(st) 2011 to May 30(th) 2012. They were divided into 3 groups: (1) To tally 1720 cases were included in the high-risk serological screening group, in which women were younger than 35 years and got high-risk results in serological screening; (2) To tally 1310 cases were included in the advanced age group, in which women's age was more than 35 years; (3) To tally 170 cases were included in the supplementary group, in which women were younger than 35 years and got low-risk results in serological screening, or women who didn't take serological screening tests. All the 3030 gravidas in group 1 and 2 didn't take invasive prenatal diagnosis because of fear of abortion or short of prenatal diagnosis. Cff-DNA were detected by next generation sequencing in Shenzhen BGI Genomics Center for clinical laboratory. Amniocentesis and karyotype analysis were provided to the positive cases and women with negative results were followed-up by telephone. RESULTS: (1) The 3200 cases took cff-DNA detection, and 31 cases got positive results, including 27 cases of trisomy 21 and 4 cases of trisomy 18. Sixteen cases of trisomy 21 and 1 case of trisomy 18 were in the high-risk serological screening group. 7 cases of trisomy 21 and 2 cases of trisomy 18 were in the advanced age group. Four cases of trisomy 21 and 1 case of trisomy 18 were in the supplementary group. (2) And the 84% (26/31) cff-DNA detecting positive cases received amniocentesis. In the 27 trisomy 21 positive cases, 23 received amniocentesis and got karyotype of 47XN, +21, with the diagnostic accordance rate of 100%. In the 4 cases who didn't take karyotype analysis, fetal anomaly (ventricular septal defect, dextrocardia and choroid plexus cyst) was found in 1 case before 20 gestational weeks; intrauterine fetal demise happened in 1 case before getting the result; 2 other cases who already had healthy children took abortion in the local hospital without taking amniocentesis. In the 4 trisomy 18 positive cases, 3 took amniocentesis, 2 of which were trisomy 18 and took abortion, the other was chimera (46, XN/47, XN, +18) with only 2% cells of trisomy 18, with no malformation found after delivery. Hypoevolutism (3 weeks less than gestational week), general hydropsy and intrauterine fetal demise happened before the other case took amniocentesis. (3) Follow up of cff-DNA negative cases:until May 30(th) 2012, no Down's baby was found in the 1230 cases with cff-DNA test negative results. CONCLUSIONS: (1) The non-invasive fetal trisomy test (NIFTY) by next generation sequencing is a safe, accurate and high throughput method for the prenatal diagnosis of trisomy-21. (2) Use NIFTY as a further screening for pregnant women with high-risk serological screening results could lower invasive prenatal diagnosis rate. (3) Cases with positive NIFTY test results should receive amniocentesis and karyotype analysis to confirm the diagnosis before abortion.
Assuntos
Aberrações Cromossômicas , DNA/sangue , Síndrome de Down/diagnóstico , Cariotipagem , Diagnóstico Pré-Natal/métodos , Adulto , Amniocentese , Aneuploidia , Cromossomos Humanos Par 18 , Cromossomos Humanos Par 21 , Síndrome de Down/genética , Feminino , Seguimentos , Idade Gestacional , Humanos , Idade Materna , Testes para Triagem do Soro Materno , Gravidez , Sensibilidade e Especificidade , Trissomia/diagnóstico , Trissomia/genéticaAssuntos
Infecção Hospitalar/epidemiologia , Vírus da Influenza A Subtipo H1N1/isolamento & purificação , Influenza Humana/transmissão , Exposição Ocupacional/estatística & dados numéricos , Adulto , China/epidemiologia , Infecção Hospitalar/transmissão , Coleta de Dados , Feminino , Pessoal de Saúde , Humanos , Influenza Humana/epidemiologia , Unidade Hospitalar de Ginecologia e Obstetrícia/estatística & dados numéricos , Pandemias , Gravidez , Complicações Infecciosas na Gravidez/epidemiologia , Risco , Adulto JovemRESUMO
In this study we have established a technique of multiple quantitative fluorescent polymerase chain reaction (QF-PCR) for prenatal diagnosis of common chromosomal abnormality using multiple short tandem repeat markers (STR-marker) on chromosomes 21 and 18 with the DNA samples from 20 cases of Down's syndrome, 3 cases of trisomy 18 and 40 cases normal controls. The technique established was applied in prenatal diagnosis in 165 clinical cases and 4 cases of newborn infants with digestive tract obstruction. The result this technique was compared with the results of karyotyping. Four cases of trisomy 21 and 1 case of trisomy 18 were identified among 169 samples, which was completely concordant with the results of karyotyping. All clinical samples were diagnosed in 1-3 days without misdiagnosis and missed diagnosis. Five cases were diagnosed by QF-PCR only due to the failure of karyotyping. Twenty-two cases of fetuses with structure malformation indicated by B-ultrasonography were subjected to karyotyping. One case of 45, X and 1 case of 47, XXY were identified. In conclusion, QF-PCR technique is rapid and accurate for the detection of trisomy 21 and trisomy 18. It is suitable for prenatal diagnosis of common chromosomal abnormality for pregnant women with advanced ages who were identified as having a high risk by serum screening. QF-PCR technique combined with karyotyping can provide better service for clinical demanding of prenatal diagnosis.